21 May 2013
Keywords: Immuron, Clostridium difficle, Monash University, Australia
Article | 31 January 2012
Australian biotechnology firm Immuron (ASX: IMC) has entered into a collaboration agreement with Australia’s Monash University to develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 January 2012
20 May 2013
© 2013 thepharmaletter.com